ABSTRACT
Multiple sclerosis (MS) is an inflammatory disease of the CNS that is associated with demyelination and axonal loss, resulting in severe neurological handicap. Current MS therapies mostly target neuroinflammation but have only a little impact on CNS myelin repair. Progress toward treatments that enhance remyelination would therefore represent major advances in MS treatment. Here, we examined the ability of TFA-12, a new synthetic compound belonging to tocopherol long-chain fatty alcohols, to promote oligodendrocyte regeneration and remyelination in experimental models of MS. We showed that TFA-12 significantly ameliorates neurological deficit and severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE) in mice. Histological evaluation of mouse EAE spinal cords showed that TFA-12 treatment reduces inflammation, astrogliosis, and myelin loss. Additionally, we demonstrated that TFA-12 accelerates remyelination of focal demyelinated lesions induced by lysolecithin injections. We also found that this compound induces the differentiation of oligodendrocyte precursor cells into mature oligodendrocytes through the inhibition of the Notch/Jagged1 signaling pathway. Altogether, our data provide important proof of principle indicating that TFA-12 could be a potential therapeutic compound for myelin repair in MS.
Subject(s)
Disease Models, Animal , Multiple Sclerosis/drug therapy , Multiple Sclerosis/pathology , Myelin Sheath/drug effects , Myelin Sheath/pathology , Tocopherols/therapeutic use , Animals , Cells, Cultured , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Mice , Mice, Inbred C57BL , Tocopherols/chemistry , Tocopherols/pharmacologyABSTRACT
Alzheimer's disease (AD) is characterized by the presence of extracellular deposits referred to beta-amyloid (Abeta) complexes or senile plaques. Abeta peptide is firstly produced as monomers, readily aggregating to form multimeric complexes, of which the smallest aggregates are known to be the most neurotoxic. In AD patients, abundant reactive microglia migrate to and surround the Abeta plaques. Though it is well known that microglia are activated by Abeta, little is known about the peptide conformation and the signaling cascades responsible for this activation. In this study, we have stimulated murine microglia with different Abeta(1-42) forms, inducing an inflammatory state, which was peptide conformation-dependent. The lightest oligomeric forms induced a more violent inflammatory response, whereas the heaviest oligomers and the fibrillar conformation were less potent inducers. BocMLF, a formylpeptide chemotactic receptor 2 antagonist, decreased the oligomeric Abeta-induced inflammatory response. The Abeta-induced signal transduction was found to depend on phosphorylation mechanisms mediated by MAPKs and on activator protein 1/nuclear factor kappa-light-chain-enhancer of activated B cells pathways activation. These results suggest that the reactive microgliosis intensity during AD might depend on the disease progression and consequently on the Abeta conformation production. The recognition of Abeta by the formylpeptide chemotactic receptor 2 seems to be a starting point of the signaling cascade inducing an inflammatory state.
Subject(s)
Amyloid beta-Peptides/chemistry , Microglia/physiology , Peptide Fragments/chemistry , Receptors, Formyl Peptide/physiology , Amyloid beta-Peptides/immunology , Amyloid beta-Peptides/physiology , Animals , Biopolymers , Cell Line , Inflammation/immunology , Inflammation/metabolism , Mice , Mice, Inbred C57BL , Microglia/immunology , Mitogen-Activated Protein Kinases/physiology , NF-kappa B/physiology , Peptide Fragments/immunology , Peptide Fragments/physiology , Phosphorylation , Protein Conformation , Signal Transduction , Transcription Factor AP-1/physiologyABSTRACT
The Notch pathway is implicated in many aspects of the central nervous system (CNS) development and functions. Recently, we and others identified the Notch pathway to be involved in inflammatory events of the CNS. To understand the implication of this pathway on astrocytes, we have studied the Jagged-Notch-Hes pathway under inflammatory conditions. LPS exposure induced an upregulation of Jagged1 expression on cultured astrocytes. To address the role of Jagged1 in the modulation of inflammation, we used a siRNA mediated silencing of Jagged1 (siRNA J1). Jagged1 inhibition induced important variations on the Notch pathway components like Hes1, Hes5, Notch3, and RBP-Jkappa. siRNA J1 repressed the mRNA expression of genes known as hallmarks of the gliosis like GFAP and endothelin(B) receptor. On activated astrocytes, the inhibition of Jagged1 had antiinflammatory effects and resulted in a decrease of LPS-induced proinflammatory cytokines (IL1beta, IL1alpha, and TNFalpha) as well as the iNOS expression. The inhibition of Jagged1 induced a modulation of the JAK/STAT/SOCS signaling pathway. Most interestingly, the siRNA J1 decreased the LPS-induced translocation of NFkappaB p65 and this could be correlated to the phosphorylation of IkappaBalpha. These results suggest that during inflammatory and gliotic events of the CNS, Jagged1/Notch signaling sustains the inflammation mainly through NFkappaB and in part through JAK/STAT/SOCS signaling pathways.
Subject(s)
Astrocytes/metabolism , Calcium-Binding Proteins/metabolism , Intercellular Signaling Peptides and Proteins/metabolism , Janus Kinases/metabolism , Membrane Proteins/metabolism , NF-kappa B/metabolism , STAT1 Transcription Factor/metabolism , Suppressor of Cytokine Signaling Proteins/metabolism , Animals , Astrocytes/drug effects , Basic Helix-Loop-Helix Transcription Factors/metabolism , Blotting, Western , Calcium-Binding Proteins/genetics , Cells, Cultured , Cytokines/metabolism , Enzyme-Linked Immunosorbent Assay , Gene Silencing , Gliosis/metabolism , Homeodomain Proteins/metabolism , Inflammation/metabolism , Intercellular Signaling Peptides and Proteins/genetics , Jagged-1 Protein , Lipopolysaccharides/metabolism , Lipopolysaccharides/toxicity , Membrane Proteins/genetics , Nitric Oxide/metabolism , RNA, Messenger/drug effects , RNA, Messenger/genetics , RNA, Small Interfering/pharmacology , Rats , Rats, Wistar , Receptor, Notch1/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Serrate-Jagged Proteins , Signal Transduction/drug effects , Signal Transduction/genetics , Signal Transduction/physiology , Transcription Factor HES-1 , Transfection , Tumor Necrosis Factor-alpha/metabolismABSTRACT
M1 and M2 are the extremes of the differentiation spectrum of activated macrophages. Since microglia are members of the same cell lineage, we have characterized their transcription profile and their phagocytic activity under different conditions. LPS or IFN-gamma induce a M1-like phenotype, while IL-10 or IL-4 differentiate microglia towards a M2-deactivated or M2-alternatively-activated phenotype respectively. These differentiation processes also affect the Notch pathway. In order to study the polarization induced by Abeta, microglia was stimulated with different forms of the peptide. The oligomeric Abeta is a stronger M1-inductor than the fibrillar form. Moreover, a cytokine-induced anti-inflammatory environment reduces the microglial reactivity towards oligomeric Abeta.
Subject(s)
Amyloid beta-Peptides/toxicity , Cell Differentiation/physiology , Encephalitis/pathology , Gliosis/pathology , Inflammation Mediators/toxicity , Microglia/cytology , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Alzheimer Disease/physiopathology , Amyloid beta-Peptides/metabolism , Animals , Cell Differentiation/drug effects , Cell Line , Cell Lineage/drug effects , Cell Lineage/physiology , Cells, Cultured , Chemotaxis/drug effects , Chemotaxis/physiology , Cytokines/genetics , Cytokines/metabolism , Cytokines/toxicity , Encephalitis/chemically induced , Encephalitis/physiopathology , Gene Expression Profiling , Gene Expression Regulation/drug effects , Gene Expression Regulation/physiology , Gliosis/chemically induced , Gliosis/physiopathology , Inflammation Mediators/metabolism , Mice , Mice, Inbred C57BL , Microglia/drug effects , Microglia/metabolism , Molecular Weight , Phenotype , Receptors, Notch/drug effects , Receptors, Notch/metabolism , Signal Transduction/drug effects , Signal Transduction/physiologyABSTRACT
The Notch signaling pathway plays a crucial role in specifying cellular fate in metazoan development by regulating communication between adjacent cells. Correlative studies suggested an involvement of Notch in hematopoietic cell development. Here, we report that the Notch pathway is expressed and active in microglial cells. During inflammatory activation, the transcription of the Notch down-stream effector Hes1 is downregulated. When Notch1 transcription in microglia is inhibited, an upregulation of the expression of pro-inflammatory cytokines is observed. Notch stimulation in activated microglia, using a soluble form of its ligand Jagged1, induces a decrease in pro-inflammatory cytokines secretion and nitric oxide production as well as an increase in phagocytic activity. Notch-stimulation is accompanied by an increase in the rate of STAT3 phosphorylation and nuclear translocation. Our results show that the Notch pathway plays an important role in the control of inflammatory reactions in the CNS.
Subject(s)
Microglia/physiology , Receptor, Notch1/genetics , Receptor, Notch1/physiology , Receptors, Notch/physiology , Signal Transduction/physiology , Animals , Animals, Newborn , Cell Line , Immunoblotting , Immunohistochemistry , Inflammation/genetics , Inflammation/pathology , Interleukin-6/biosynthesis , Mice , Nitric Oxide/metabolism , Oligonucleotides, Antisense/pharmacology , Phagocytosis/physiology , Phosphorylation , RNA, Small Interfering/pharmacology , Rats , Rats, Wistar , Reverse Transcriptase Polymerase Chain Reaction , STAT3 Transcription Factor/genetics , STAT3 Transcription Factor/physiology , Transcription Factor RelA/genetics , Transcription Factor RelA/metabolism , Translocation, Genetic/physiology , Tumor Necrosis Factor-alphaABSTRACT
The synthesis of resveratrol fatty alcohols (RFAs), a new class of small molecules presenting strong potential for the treatment of neurological diseases, is described. RFAs, hybrid compounds combining the resveratrol nucleus and omega-alkanol side chains, are able to modulate neuroinflammation and to induce differentiation of neural stem cells into mature neurons. Acting on neuroprotection and neuroregeneration, RFAs represent an innovative approach for the treatment or cure of neuropathies.
Subject(s)
Cell Differentiation/drug effects , Fatty Alcohols/pharmacology , Inflammation/pathology , Nervous System/drug effects , Stem Cells/drug effects , Stilbenes/pharmacology , Animals , Cell Line , Mice , Nervous System/cytology , ResveratrolABSTRACT
The synthesis of a series of Tocopherol long chain Fatty Alcohols (TFA) and their biological activities on the modulation of microglial activation are described. Specifically, the 2-(12-hydroxy-dodecyl)-2,5,7,8-tetramethyl-chroman-6-ol, the TFA bearing 12 carbon atoms on the side chain (n=12), shows the most potent inhibition of secretion on nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) by lipopolysaccharide (LPS)-activated microglia.
